ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,824Medicare Part D Prescriptions Filled, Including Refills

Rank: 170 out of 1171

$593K Total Retail Price of All Prescriptions

Rank: 153 out of 1171

275 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 275 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 275 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 8,497 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
WARFARIN SODIUM 420 418 1 12
FUROSEMIDE 340 301 2 6
LISINOPRIL 270 219 3 3
OMEPRAZOLE 264 237 4 5
SIMVASTATIN 252 215 5 1
LEVOTHYROXINE SODIUM 248 224 6 4
AMLODIPINE BESYLATE 225 193 7 2
QUETIAPINE FUMARATE 223 208 8 54
DONEPEZIL HCL 185 185 9 24
MIRTAZAPINE 183 172 10 50
METOPROLOL TARTRATE 179 164 11 11
CITALOPRAM HBR 164 151 12 22
GABAPENTIN 163 135 13 16
SERTRALINE HCL 157 134 14 23
ALBUTEROL SULFATE 138 123 15 102
POLYETHYLENE GLYCOL 3350 135 130 16 72
NOVOLOG FLEXPEN 135 113 16 157
HYDROCHLOROTHIAZIDE 122 101 18 9
TRAZODONE HCL 122 80 18 37
ATORVASTATIN CALCIUM 122 106 18 10
POTASSIUM CHLORIDE 114 109 21 19
METOPROLOL SUCCINATE 104 90 22 17
ESCITALOPRAM OXALATE 100 90 23 69
CLONIDINE HCL 92 88 24 45
HYDRALAZINE HCL 91 77 25 60
NAMENDA 89 89 26 42
METFORMIN HCL 88 65 27 7
DIVALPROEX SODIUM 83 57 28 106
TRAMADOL HCL 79 78 29 18
TAMSULOSIN HCL 78 73 30 28
GLIPIZIDE 75 63 31 47
CLOPIDOGREL 73 60 32 35
OLANZAPINE 72 48 33 153
DIOVAN 71 71 34 32
CIPROFLOXACIN HCL 71 68 34 61
CARVEDILOL 69 63 36 20
LEVOFLOXACIN 69 63 36 105
SPIRIVA 68 59 38 57
ISOSORBIDE MONONITRATE ER 68 68 38 44
LEVEMIR FLEXPEN 68 68 38 145
HYDROCODONE-ACETAMINOPHEN 66 37 S3 41 8
FAMOTIDINE 62 55 42 75
AZITHROMYCIN 56 48 43 43
RISPERIDONE 56 43 43 77
PANTOPRAZOLE SODIUM 55 44 45 29
SEROQUEL 55 55 45 120
LANTUS SOLOSTAR 54 43 47 90
LIDODERM 52 50 48 98
LOSARTAN POTASSIUM 51 51 49 14
FLUTICASONE PROPIONATE 51 39 49 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 11, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.